Robert Shigeo Ohgami, MD
Pathology · Salt Lake City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 18 years
- Harvard Medical School, 2008
Offices
1 location · University of Utah Adult Services · 1,758 clinicians in this group
Looking this up.
Hospitals listed: University of Utah Hospital and Clinics. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ohgami’s office at (801) 585-6387 to ask if they take your plan before you enroll.
California Medical Board record
Licence A109472 · Current
Licensed to practise in California · since 2009 · expires 2027-03-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- University of Utah Hospital and ClinicsSalt Lake City, UTAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of University of Utah Hospitals and Clinics, which runs 2 hospitalsHome of Huntsman Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.603, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.55, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.518, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.595, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.8 (7.3 to 10.3) · 1,119 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for University of Utah Hospital and Clinics
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 2 better, 8 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.603 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.55 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.518 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.595 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.8 (7.3 to 10.3) · 1,119 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.78 (0.03 to 1.53) · 3,231 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.6 to 1.22) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 156.56 (123.99 to 189.13) · 297 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 168 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 423 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.7 · 347 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.8 · 506 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,004 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0.02 to 0.37) · 11,361 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.08 to 0.43) · 12,089 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.06 (2.7 to 5.41) · 4,881 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.58 (0 to 3.27) · 204 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.55 (1.5 to 3.59) · 4,443 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.76 (0 to 15.4) · 212 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.49 (1.4 to 9.58) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.88 (0.63 to 3.14) · 1,317 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0.08 to 0.92) · 10,150 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.8 · 289 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.204 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.738 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 213 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.5 · 664 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 180 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -34.8 · 478 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -7 · 374 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 535 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.8 (4.6 to 7) · 1,119 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.2 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.9 to 15.8) · 2,684 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.2) · 2,156 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,497 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$4,005
Medicare paid this office $4,005 for 38 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Molecular pathology procedure; physician interpretation and report | 16 | $539 | $34 |
Who their Medicare patients are
38 Original Medicare patients in 2024. Average age 74 · Women 37% · Health risk score 2.43. Above the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Chronic kidney disease 37% · Coronary heart disease 34% · Depression 32% · Heart failure 29% · Atrial fibrillation 29%.
The office billed $17,591, Medicare allowed $5,085 and paid $4,005; for 138 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 38 | 138 | 74 | 2.43 | $17,591 | $4,005 |
| 2023 | 49 | 64 | 73 | 2.37 | $6,449 | $2,294 |
| 2022 | 78 | 664 | 73 | 2.06 | $161,998 | $22,127 |
| 2021 | 102 | 1,021 | 76 | 1.96 | $259,962 | $35,716 |
| 2020 | 107 | 1,153 | 73 | 2.00 | $277,114 | $41,045 |
| 2019 | 144 | 807 | 72 | 2.61 | $184,008 | $29,588 |
| 2018 | 241 | 1,098 | 72 | 2.13 | $274,014 | $43,782 |
| 2017 | 242 | 981 | 71 | 2.17 | $242,817 | $39,228 |
| 2016 | 216 | 808 | 72 | 2.28 | $206,950 | $34,696 |
| 2015 | 255 | 934 | 72 | 2.07 | $235,527 | $39,690 |
| 2014 | 268 | 1,053 | 71 | 2.24 | $281,066 | $42,026 |
| 2013 | 205 | 587 | 70 | 2.36 | $155,829 | $25,097 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Molecular pathology procedure; physician interpretation and report | 39 | $1,408 | $35 |
2022: 10 services
| Special stained specimen slides to examine tissue, each additional procedure | 37 | $8,119 | $26 |
| Microscopic genetic analysis of tumor, manual | 35 | $4,658 | $38 |
| Special stained specimen slides to examine tissue, initial procedure | 38 | $1,356 | $32 |
| Molecular pathology procedure; physician interpretation and report | 32 | $1,320 | $40 |
| Pathology examination of tissue using a microscope, moderately high complexity | 12 | $1,275 | $75 |
| Pathology examination of tissue using a microscope, intermediate complexity | 21 | $1,231 | $34 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 15 | $1,134 | $76 |
| Bone marrow, smear interpretation | 19 | $823 | $43 |
| Genetic sequencing localization, initial procedure | 15 | $633 | $40 |
| Special stained specimen slides to examine tissue including interpretation and report | 11 | $186 | $11 |
2021: 11 services
| Special stained specimen slides to examine tissue, each additional procedure | 61 | $12,330 | $27 |
| Microscopic genetic analysis of tumor, manual | 56 | $8,594 | $39 |
| Special stained specimen slides to examine tissue, initial procedure | 68 | $2,459 | $33 |
| Pathology examination of tissue using a microscope, intermediate complexity | 33 | $2,279 | $35 |
| Pathology examination of tissue using a microscope, moderately high complexity | 21 | $1,786 | $78 |
| Molecular pathology procedure; physician interpretation and report | 39 | $1,655 | $42 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 20 | $1,550 | $78 |
| Genetic sequencing localization, initial procedure | 28 | $1,179 | $41 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 13 | $1,052 | $81 |
| Bone marrow, smear interpretation | 23 | $1,038 | $45 |
| Special stained specimen slides to examine tissue including interpretation and report | 18 | $247 | $11 |
2020: 9 services
| Special stained specimen slides to examine tissue, each additional procedure | 68 | $15,929 | $27 |
| Microscopic genetic analysis of tumor, manual | 59 | $9,231 | $41 |
| Pathology examination of tissue using a microscope, moderately high complexity | 37 | $4,013 | $80 |
| Special stained specimen slides to examine tissue, initial procedure | 71 | $2,652 | $34 |
| Pathology examination of tissue using a microscope, intermediate complexity | 35 | $2,440 | $36 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 21 | $1,683 | $80 |
| Genetic sequencing localization, initial procedure | 35 | $1,639 | $42 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 12 | $921 | $77 |
| Special stained specimen slides to examine tissue including interpretation and report | 11 | $150 | $12 |
2019: 14 services
| Special stained specimen slides to examine tissue, each additional procedure | 53 | $7,973 | $27 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 32 | $2,503 | $78 |
| Pathology examination of tissue using a microscope, intermediate complexity | 54 | $2,495 | $36 |
| Special stained specimen slides to examine tissue, initial procedure | 63 | $2,367 | $34 |
| Microscopic genetic analysis of tumor, manual | 38 | $2,222 | $40 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 25 | $2,074 | $83 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 25 | $1,992 | $80 |
| Bone marrow, smear interpretation | 36 | $1,765 | $46 |
| Genetic sequencing localization, initial procedure | 32 | $1,418 | $42 |
| Pathology examination of tissue using a microscope, moderately high complexity | 14 | $1,346 | $79 |
| Genetic sequencing localization, each additional procedure | 18 | $695 | $33 |
| Special stained specimen slides to examine tissue including interpretation and report | 22 | $480 | $11 |
| Preparation of tissue for examination by removing any calcium present | 37 | $462 | $12 |
| Cell examination of specimen, concentration technique | 17 | $366 | $20 |
2018: 14 services
| Special stained specimen slides to examine tissue, each additional procedure | 63 | $8,965 | $27 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 73 | $5,709 | $78 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 57 | $4,688 | $82 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 58 | $4,673 | $79 |
| Microscopic genetic analysis of tumor, manual | 52 | $3,112 | $43 |
| Special stained specimen slides to examine tissue, initial procedure | 80 | $3,046 | $34 |
| Bone marrow, smear interpretation | 61 | $2,996 | $46 |
| Pathology examination of tissue using a microscope, intermediate complexity | 68 | $2,854 | $36 |
| Genetic sequencing localization, initial procedure | 40 | $1,975 | $42 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 12 | $1,017 | $60 |
| Preparation of tissue for examination by removing any calcium present | 60 | $782 | $12 |
| Genetic sequencing localization, each additional procedure | 19 | $761 | $33 |
| Special stained specimen slides to examine tissue including interpretation and report | 27 | $620 | $11 |
| Cell examination of specimen, concentration technique | 24 | $561 | $22 |
2017: 14 services
| Special stained specimen slides to examine tissue, each additional procedure | 61 | $7,483 | $27 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 69 | $5,545 | $78 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 53 | $4,479 | $83 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 44 | $3,409 | $77 |
| Bone marrow, smear interpretation | 68 | $3,359 | $45 |
| Pathology examination of tissue using a microscope, intermediate complexity | 70 | $2,886 | $36 |
| Special stained specimen slides to examine tissue, initial procedure | 72 | $2,716 | $34 |
| Microscopic genetic analysis of tumor, manual | 31 | $1,875 | $52 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 11 | $1,673 | $60 |
| Genetic sequencing localization, initial procedure | 29 | $1,174 | $40 |
| Cell examination of specimen, concentration technique | 39 | $862 | $21 |
| Preparation of tissue for examination by removing any calcium present | 65 | $853 | $12 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 11 | $762 | $69 |
| Special stained specimen slides to examine tissue including interpretation and report | 29 | $484 | $11 |
2016: 15 services
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 72 | $7,560 | $101 |
| Special stained specimen slides to examine tissue, each additional procedure | 34 | $4,822 | $25 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 45 | $3,620 | $79 |
| Bone marrow, smear interpretation | 63 | $2,870 | $44 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 25 | $2,510 | $81 |
| Pathology examination of tissue using a microscope, intermediate complexity | 61 | $2,484 | $35 |
| Microscopic genetic analysis of tumor, manual | 26 | $2,151 | $51 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 21 | $1,697 | $81 |
| Special stained specimen slides to examine tissue, initial procedure | 41 | $1,551 | $34 |
| Genetic sequencing localization, initial procedure | 20 | $830 | $41 |
| Flow cytometry technique for dna or cell analysis, 2 to 8 markers | 11 | $785 | $65 |
| Preparation of tissue for examination by removing any calcium present | 52 | $635 | $12 |
| Cell examination of specimen, concentration technique | 23 | $602 | $22 |
| Special stained specimen slides to examine tissue including interpretation and report | 23 | $494 | $11 |
| Blood smear interpretation by physician with written report | 19 | $461 | $23 |
2015: 16 services
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 95 | $10,112 | $101 |
| Pathology examination of tissue using a microscope, intermediate complexity | 83 | $3,366 | $35 |
| Bone marrow, smear interpretation | 73 | $3,275 | $44 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 40 | $3,035 | $76 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 30 | $3,028 | $82 |
| Special stained specimen slides to examine tissue, each additional procedure | 44 | $3,005 | $20 |
| Microscopic genetic analysis of tumor, manual | 31 | $2,016 | $50 |
| Special stained specimen slides to examine tissue, initial procedure | 50 | $1,729 | $33 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 21 | $1,697 | $81 |
| Flow cytometry technique for dna or cell analysis, 2 to 8 markers | 25 | $1,689 | $65 |
| Genetic sequencing localization, initial procedure | 24 | $976 | $41 |
| Preparation of tissue for examination by removing any calcium present | 72 | $843 | $11 |
| Blood smear interpretation by physician with written report | 33 | $772 | $23 |
| Cell examination of specimen, concentration technique | 33 | $708 | $20 |
| Microscopic genetic analysis of tissue, manual, initial procedure | 12 | $488 | $41 |
| Special stained specimen slides to examine tissue including interpretation and report | 24 | $348 | $11 |
2014: 14 services
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 117 | $12,539 | $96 |
| Bone marrow, smear interpretation | 112 | $5,572 | $43 |
| Pathology examination of tissue using a microscope, intermediate complexity | 121 | $5,205 | $34 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 43 | $3,496 | $71 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 27 | $2,246 | $77 |
| Microscopic genetic analysis of tumor, manual | 33 | $2,215 | $48 |
| Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | 30 | $1,479 | $11 |
| Preparation of tissue for examination by removing any calcium present | 108 | $1,370 | $11 |
| Genetic sequencing localization, initial procedure | 13 | $1,239 | $54 |
| Flow cytometry technique for dna or cell analysis, 2 to 8 markers | 19 | $1,207 | $64 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 34 | $1,020 | $28 |
| Special stained specimen slides to examine tissue including interpretation and report | 45 | $761 | $11 |
| Cell examination of specimen, concentration technique | 33 | $737 | $20 |
| Blood smear interpretation by physician with written report | 27 | $660 | $22 |
2013: 12 services
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 81 | $7,505 | $89 |
| Bone marrow, smear interpretation | 67 | $3,185 | $42 |
| Special stained specimen slides to examine tissue, initial procedure | 18 | $2,947 | $38 |
| Pathology examination of tissue using a microscope, intermediate complexity | 62 | $2,324 | $33 |
| Flow cytometry technique for dna or cell analysis, 2 to 8 markers | 32 | $1,965 | $60 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 22 | $1,948 | $75 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 13 | $1,143 | $76 |
| Microscopic genetic analysis of tumor, manual | 13 | $1,119 | $47 |
| Cell examination of specimen, concentration technique | 39 | $789 | $17 |
| Preparation of tissue for examination by removing any calcium present | 61 | $748 | $11 |
| Blood smear interpretation by physician with written report | 28 | $596 | $21 |
| Special stained specimen slides to examine tissue including interpretation and report | 20 | $297 | $11 |
Medicaid work
$1,357 in 2019
Medicaid paid $1,357 for 42 billed services this clinician did in 2019, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique) | 42 | $1,357 |
| 2019 | 42 | 1 | 15 | $1,357 |
| 2018 | 47 | 1 | 19 | $1,495 |
See the largest Medicaid services in earlier years
2018
| Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique) | 47 | $1,495 |
Money from drug and device companies
$10,882 in 2025
| 2025 | 3 | 4 | $10,882 | $10,882 |
| 2024 | 1 | 10 | $9,278 | $9,772 |
| 2022 | 1 | 10 | None | $597 |
| 2021 | 2 | 4 | $4,320 | $4,411 |
| 2019 | 1 | 9 | $3,200 | $4,469 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Recordati Rare Diseases Inc. | Sylvant | $5,085 | 2 payments
|
| Beckman Coulter | None | $4,237 | 1 payment
|
| Stemline Therapeutics | Elzonris | $1,560 | 1 payment
|
See all 4 published payments
| Stemline Therapeutics | Consulting · 2025-07-30 | Elzonris | $1,560 |
| Recordati Rare Diseases Inc. | Consulting · 2025-03-26 | Sylvant | $1,695 |
| Recordati Rare Diseases Inc. | Honoraria · 2025-02-04 | Sylvant | $3,390 |
| Beckman Coulter | Consulting · 2025-02-04 | None | $4,237 |
See earlier years (2024, 2022, 2021, 2019)
2024: $9,772
| Recordati Rare Diseases Inc. | Sylvant | $9,772 | 10 payments
|
2022: $597
| Illumina | Novaseq 6000dx Sequencer Instrument | $597 | 5 payments
|
2021: $4,411
| Stemline Therapeutics | Elzonris | $2,400 | 1 payment
|
| Blueprint Medicines | None | $2,011 | 3 payments
|
2019: $4,469
| Stemline Therapeutics | Elzonris | $4,469 | 9 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 92.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1902109564
- Licence
- CA A109472, UT 12919332-1205California A109472: Current · expires 2027-03-31
- Trained
- Harvard Medical School, 2008 · 18 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207ZP0101X (207ZP0101X); Federal specialty code 207ZH0000X (207ZH0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-12-20
- NPI last updated
- 2022-08-28
- NPI record certified
- 2022-08-28
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.